Lakefront Biotherapeutics NV

LKFT

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001421876

SEC filings (opens in a new tab)

No open-market purchases or sales by Lakefront Biotherapeutics NV insiders were filed in the last 90 days; 76 institutions reported holding it in 13F filings for Q2 2026, worth $960.3M in total; Greenlight Capital is the only superinvestor holding it.

Other share classesGLPGF

Q1 2022 vs. Q4 2021

How the institutions holding Lakefront Biotherapeutics NV changed between Q4 2021 and Q1 2022.

All holders in Q1 2022 All holders in Q4 2021

13F holders of LKFT: Q4 2021 compared with Q1 2022
Measure	Q4 2021	Of which not filed for Q1 2022	Q1 2022	Change
Holders	83	1	90	+8
Shares	10.8M	31.0K	12.8M	+2.07M (+19.2%)
Value	$595.0M	$1.71M	$795.8M	+$202.5M (+34.1%)

1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (24)

Institutions that held Lakefront Biotherapeutics NV at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to LKFT in Q1 2022
Institution	Shares	Value	% of portfolio
Driehaus Capital Management LLC	477,615	$29.6M	0.36%
Deutsche Bank AG	294,207	$18.2M	0.01%
Tang Capital Management LLC	250,000	$15.5M	3.14%
Avidity Partners Management LP	215,000	$13.3M	0.30%
Bridger Management, LLC	153,700	$9.53M	1.56%
Newtyn Management, LLC	113,400	$7.03M	1.68%
Endurant Capital Management LP	52,400	$3.25M	0.98%
Arrowstreet Capital, Limited Partnership	31,986	$1.98M	0.00%
HealthCor Management, L.P.	23,740	$1.47M	0.10%
Parametric Portfolio Associates LLC	13,664	$847.0K	0.00%
HighVista Strategies LLC	13,209	$819.0K	0.52%
Calamos Advisors LLC	10,555	$655.0K	0.00%
Connective Portfolio Management, LLC	10,000	$643.0K	1.42%
American Century Companies Inc	6,707	$416.0K	0.00%
Ergoteles LLC	5,971	$370.0K	0.01%
Dimensional Fund Advisors LP	4,027	$250.0K	0.00%
State Street Corp	3,898	$242.0K	0.00%
Simplex Trading, LLC	1,994	$123.0K	0.00%
Group One Trading, L.P.	642	$40.0K	0.00%
Zurcher Kantonalbank (Zurich Cantonalbank)	547	$34.0K	0.00%
Acadian Asset Management LLC	412	$25.0K	0.00%
IFP Advisors, Inc	74	$8.00K	0.00%
AdvisorNet Financial, Inc	54	$3.00K	0.00%
Money Concepts Capital Corp	2	$0	0.00%

Sold out (16)

Institutions that held Lakefront Biotherapeutics NV at the end of Q4 2021 and filed for Q1 2022 without it.

Institutions that sold out of LKFT in Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
Paradigm Biocapital Advisors LP	167,824	$9.25M
Soleus Capital Management, L.P.	98,800	$5.45M
Brookfield Asset Management Inc.	66,805	$3.68M
Voloridge Investment Management, LLC	49,002	$2.70M
ExodusPoint Capital Management, LP	36,372	$2.00M
J. Goldman & Co LP	27,972	$1.54M
Parallax Volatility Advisers, L.P.	26,800	$1.48M
Eqis Capital Management, Inc.	23,621	$1.30M
HAP Trading, LLC	22,218	$1.23M
Alliancebernstein L.P.	20,000	$1.10M
Capital International Inc	10,653	$587.0K
CSS LLC	7,458	$411.0K
Knott David M Jr	7,000	$386.0K
Marshall Wace, LLP	6,225	$344.0K
Pacer Advisors, Inc.	280	$15.0K
Bedel Financial Consulting, Inc.	25	$1.00K

Not filed for Q1 2022 yet (1)

Institutions that held Lakefront Biotherapeutics NV at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding LKFT in Q4 2021 that haven't filed for Q1 2022
Institution	Shares, Q4 2021	Value, Q4 2021
AlphaCentric Advisors LLC	31,000	$1.71M